JAMDAxxx(2020)1e10
JAMDA
journal homepage: www.jamda.com
Original Study
Effects of Exergaming on Cognitive and Social Functioning of People
with Dementia: A Randomized Controlled Trial
Joeke van Santen MSca,b,*, Rose-Marie Dröes PhDa,b, Jos W.R. Twisk PhDb,c,
Olivier A. Blanson Henkemans PhDd, Annemieke van Straten PhDe,
Franka J.M. Meiland PhDa,b
aDepartmentofPsychiatry,AmsterdamUMC,VUmc,Amsterdam,theNetherlands
bAmsterdamPublicHealthResearchInstitute,Amsterdam,theNetherlands
cDepartmentofEpidemiologyandBiostatistics,AmsterdamUMC,VUmc,Amsterdam,theNetherlands
dChildHealth,TNO,Leiden,theNetherlands
eDepartmentofClinical-Neuro-andDevelopmentalPsychology,FacultyofBehaviourandMovementSciences,VrijeUniversiteitAmsterdam,the
Netherlands
a b s t r a c t
Keywords: Objectives: Physical activity in people with dementia (PwD) may enhance physical and mental func-
Randomizedcontrolledtrial tioning. Exergaming, which combines physical exercise with cognitive stimulation in a gaming envi-
dementia ronment,wasdevelopedtoovercomebarriersinperformingphysicalactivities.Weevaluatedtheeffects
exergaming
ofexergamingindaycarecenters(DCCs)forPwDandinformalcaregivers(ICs).
physicalactivity
Design:Arandomizedcontrolledtrialamong23DCCsacrosstheNetherlandsrandomizedtoexergaming
cognition
(interactivecyclingduring6months)oracare-as-usualcontrolgroup.
socialbehavior
SettingandParticipants:Atotalof112(73exergaming,39control)community-dwellingdyads(PwD,IC),
withthePwDvisitingaDCCatleasttwiceperweek.
Methods:AlloutcomeswereassessedusingstructuredquestionnairesduringinterviewswithPwDand
ICsatbaseline(T0),3months(T1),and6months(T2).Primaryoutcomes:physicalactivityandmobility
ofthePwD.Secondaryoutcomes:physical,cognitive,emotionalandsocialfunctioning,andqualityoflife
forPwD.ForICs:experiencedburden,qualityoflife,andpositivecareexperiences.
Results: Mixed-model analyses showed no statistically significant effects onprimary outcomes. There
were statistically significant positive effects on PwD’s secondary outcomes at T2 on cognition [Mini-
Mental State Examination (MMSE): r ¼ 2.30, 95% confidence interval (CI): 0.65, 3.96, P ¼.007; and
Trail Making Test part A (TMT-A): r ¼ (cid:2)28.98, 95% CI: (cid:2)54.89, (cid:2)3.08, P ¼.029], social functioning
(BehaviorObservationScaleforIntramuralPsychogeriatricssubscale1(GIP):r¼(cid:2)1.86,95%CI:(cid:2)3.56,
(cid:2)0.17,P¼.031),andpositivepost-testeffectsinICsondistresscausedbythePwD’sneuropsychiatric
symptoms(NPI-Qtotaldistress:r¼(cid:2)3.30,95%CI:(cid:2)6.57,(cid:2)0.03,P¼.048)andonsenseofcompetence
(SSCQ:r¼2.78,95%CI:0.85,4.71,P¼.005).
ConclusionsandImplications:Exergamingappearednoteffectiveontheprimaryoutcomes.Despitethe
studybeingunderpowered,wefoundpositiveeffectsonsecondaryoutcomesforPwDandICs,andno
negativeeffects.Wethereforerecommendfurtherstudy,dissemination,andimplementation.
(cid:1)2020AMDAeTheSocietyforPost-AcuteandLong-TermCareMedicine.Thisisanopenaccessarticle
undertheCCBYlicense(http://creativecommons.org/licenses/by/4.0/).
Fundingsources:TheresearchprojectreceivedfundingfromZonMw-Memo-
* Address correspondence to Joeke van Santen, MSc, Department of Clinical-,
rabel programme/ Alzheimer Nederland (project number 733050609), Stichting
Neuro- and Developmental Psychology, Faculty of Behavioural and Movement
Dioraphte(projectnumber16020403),andtheEU.Thistrialwascarriedoutas
Sciences,VrijeUniversiteitAmsterdam,RoomMF-B547,VanderBoechorststraat7,
partoftheMarieSk1odowskaCuriefundedINDUCTInnovativeTrainingNetwork
1081BTAmsterdam,theNetherlands.
(ITN)(InterdisciplinaryNetworkforDementiaUsingCurrentTechnology(INDUCT),
E-mailaddress:j.vandermolen@amsterdamumc.nl(J.vanSanten).
H2020-MSCA-ITN-2015,undergrantagreementnumber676265.
Theauthorsdeclarenoconflictsofinterest.
https://doi.org/10.1016/j.jamda.2020.04.018
1525-8610/(cid:1)2020AMDAeTheSocietyforPost-AcuteandLong-TermCareMedicine.ThisisanopenaccessarticleundertheCCBYlicense(http://creativecommons.org/
licenses/by/4.0/).
2 J.vanSantenetal./JAMDAxxx(2020)1e10
Beingphysicallyactivenotonlybenefitsphysicalfunctioning,but experienced, and positive care experiences. This study is part of a
alsocognitive,emotional,andsocialfunctioningandqualityoflife.1e3
larger study in which cost-effectiveness and implementation of
Thisalsoappliestopeoplelivingwithdementia(PwD).4e6However,
exergamingforPwDinDCCswerealsostudied.
PwD may experience barriers being physically active, for example,
because of impaired orientation abilities or risk of falling.7 Psycho-
socialissuesmayalsoplayarole,suchasalackofconfidenceintheir Methods
ability to perform exercises and negative attitudes of the people
around them toward physical activities.8 Other dementia-related StudyDesign
symptomsmayalsoimpedebeingactive,forexample,adecreaseof
motivationandinterestoranincreaseofapathy.9,10Ingeneral,older We performed a cluster randomized controlled trial. Random
people tend not to achieve the recommended amount of physical allocation software was used by an independent researcher to
activity(30minutes/day),andthisworsensafteradmissionintores- randomizeDCCstotheexperimental(exergaming)orcontrol(tradi-
identialcare.11e13 tional, nonexergaming activities) group.30 The DCC staff recruited
Exergaming is an innovative form of physical exercise used for dyads(PwD,IC)forthestudy.Measurementstookplaceatbaseline
differenttargetgroupsandfordifferentaims,suchasphysicaledu- (T0)andafter3(T1)and6months(T2).Thestudywasregisteredat
cation for school children, rehabilitation for cancer patients, and the Netherlands Trial Register (NTR5537/NL5420) and approved by
cognitive rehabilitation for people with neurologic disorders (eg, the Medical Ethics Committee (METc) of the Amsterdam University
dementia).14e16 It can be defined as “physical exercise interactively MedicalCenters(UMC),locationVUUniversitymedicalcenter(VUmc;
combinedwithcognitivestimulationinagamingenvironment.”17The NL58227.029.16). All DCCs signed a declaration of participation. All
movementsoftheparticipantareregisteredusingsensorsandinflu- PwDandICsgavewritteninformedconsent.Thestudyprotocolwas
enceagameonascreen.18Anexampleisinteractivecycling.Partici- publishedelsewhereandissummarizedhere.31
pants sit on a stationary bicycle and pick a route on a screen. The
cyclingpacedeterminesthespeedofthefilm.17
ExergamingcanhelpPwDovercomebarrierstheyexperiencewith ParticipantsandSetting
regardtophysicalexercise,forexample,becausetheydonothaveto
worry about wandering and getting lost or weather conditions. A convenience sample of psychogeriatric DCCs were recruited
Exergamingcancontributetoadecreaseofapathyandpromotesocial acrosstheNetherlands.InclusioncriteriaforPwDwereasfollows:all
contact,becauseitisfunandoneengageswithothersabouttheim- ages,community-dwelling,adiagnosisofanytypeofdementia,visits
agesonthescreen,whichcanmotivateparticipation.18,19Thismayadd theDCCatleast2daysperweek,hasanICwillingtoparticipate,and
toapositiveattitudetowardexerciseinthosewhoarelessinterested arenotexpectedtobeadmittedintoresidentialcareinthecoming
in the physical activity itself. Their performance in the exergaming 6months.Exclusioncriteriawereasfollows:severephysicaldisorders
activity is something PwD can talk about with their informal care- or (terminal) diseases (other than dementia) that would make
givers (ICs), which can evoke positive feelings in both.20 Moreover, participationinanexergamingactivityimpossible(accordingtoDCC
somestudiesamongolderpeoplewith andwithoutdementiahave staff).Figure1showstheenrollmentandallocationprocessandrea-
shown that they enjoyed the exergaming activity and as a conse- sonsfordropout.
quence wanted to exercise more often and longer.19,20 Interactive
cycling, which also stimulates cognitive functioning, is a promising
exergaming intervention, as evidenced by neurologic research in ExergamingGroup
which older people participating in exergaming showed enhanced
neuroplasticity and therefore a reduced risk of developing clinical Theexergaminginterventionwasinteractivecyclingusingasta-
Mild Cognitive Impairment compared to traditional exercise.21 This tionarybicycle(ie,hometrainer)connectedtoascreen.Whilecycling,
suggests that simultaneous cognitive and physical exercise has po- the PwD sees a route on the screen. They can pick a route, and it
tentialtopreventcognitivedecline. mimicstheexperienceofcyclingoutside,thusofferingsimultaneous
Thereissomeresearchavailableabouttheeffectsofexergaming physicalandcognitivestimulation.Forthisstudy,DCCshadtobuyor
forPwD.Twosystematicliteraturereviewsfoundeffectsonphysical, leaseoneofthefollowingsystemsatadiscount:DiFiets,Fietslabyrint,
cognitive, and emotional functioning, but the samples sizes of the PraxFit,orSilverFitMile.31Variousbrandsofequipmentwereused,
included studies were small and their quality, on average, medi- but according to experts and care professionals involved in exer-
ocre.14,17Somestudiesalsofoundimprovementson(motor-)cognitive gaming,thesedidnotvarysignificantly.Thecostsrangedfrom1500to
performance,psychomotorspeed,activitiesofdailyliving,andquality 4700euros.
of life.20,22e24 However, to corroborate these findings, more high- TheDCCstaffwereresponsibleforcarryingouttheintervention.In
qualityclinicaltrialswithlargersamplesarerequired. a1-hourmeetingwiththeinvestigator,theywereinstructedtooffer
DementiaalsoaffectsfamilyorfriendsofPwD.Theymaybecome exergaming5timesperweekaspartoftheirregularactivityprogram
ICs, which can lead to stress-related symptoms, high burden, and andtoencourageresearchparticipantstotakepartatleasttwiceper
reduced quality of life.25,26 Neuropsychiatric symptoms and behav- weekfor6months.Theywerealsoofferedafreetrainingaboutthe
ioral problems of the PwD are (bidirectionally) related to caregiver use of the exergaming equipment by the provider of the chosen
burden.27,28ExergamingbytheICcanpositivelyimpactthequalityof exergame(s).However,noneoftheDCCsmadeuseofthisoffer.Apart
lifeof ICs, althoughthe evidencetodateis limited.20,29 Thereisno fromexergaming,PwDjoinedtheregularactivityprogramoftheDCC.
evidenceyetwhetherexergamingbythePwDindirectlyaffectstheICs
whentheydonotperformexergamingthemselves.17
Theobjectiveofthisstudywastoinvestigatewhetherexergaming ControlGroup
has positive effects on performance of physical activities, mobility,
physical,cognitive,emotional,andsocialfunctioning,andqualityof Psychogeriatric DCCs usually offer a varied activity program, for
lifeascomparedtoactivitiesusuallyofferedtocommunity-dwelling example, with arts and crafts, music, and physical exercise such as
PwD visiting psychogeriatric day care centers (DCCs). Additionally, walkingoutdoors5daysperweek.Inthecontrolgroup,participants
for ICs, positive effects were examined on quality of life, burden joinedtheregularactivityprogrambutwerenotofferedexergaming.
Dropout (n = 1)
due to
reorganiza(cid:2)on
PwD & IC (n= 73) PwD & IC (n = 39)
Baseline (T0)
measurements
Pw D (n = 68) &
IC (n = 65)
3-month
follow-up (T1)
PwD (n = 60) &
IC (n = 53)
6-month
follow-up (T2)
PwD (n = 52) &
IC (n = 42)
PrimaryOutcomeMeasures mobilitydisabilityinolderadultsandconsistsof3subtests:balance,
gaitspeed,andchairstands.Totalscoresrangebetween0and12,with
PrimaryoutcomeswerephysicalactivityandmobilityofthePwD. thefollowingcategories:goodfunctioningandnoriskofdeveloping
Allphysicalactivitieswererecorded(inminutes)atDCCsandathome mobility disability (10-12), elevated risk (4-9), and loss of mobility
during7daysateachmeasurement(T0,T1,T2)byDCCstaffandICs alreadybeingpresent(0-3).33
usingaspecificallydevelopedform.ThetimespentbyPwDonexer-
gamingwasalsorecordedonthisform.Weusedthetotalnumberof SecondaryOutcomeMeasures
minutesperweek(T0,T1,T2)fortheanalysis.Tomeasuremobility,
theinterviewersadministeredtheShortPhysicalPerformanceBattery SecondaryoutcomesforPwDwerecognitive,emotional,andsocial
at DCCs.32 The Short Physical Performance Battery evaluates lower functioning; quality of life; and other physical outcomes than the
extremity functioning, which is strongly correlated with a risk of primary outcome. For ICs, we assessed the subjective caregivers
no(cid:2)acollA
tnemllornE
no(cid:2)nevretni
shtnom-6
pu-wolloF
J.vanSantenetal./JAMDAxxx(2020)1e10 3
Randomiza(cid:2)on of
daycare centers
(n = 23)
Daycare centers Daycare centers
par(cid:2)cipate in par(cid:2)cipate in control
experimental group group (n = 11)
(n = 12)
Dropout PwD (n = 6) due to:
Dropout (n = 2) due
- Admission into care home (exp: n = 1)
to randomiza(cid:2)on in
- -Aphasia (cont: n = 1)
control group &
- IC wants PwD to stop (exp: n = 1)
difficult recruitment
- Wants to stop (exp: n =3)
Dropout IC (n = 12) due to:
- Admission PwD into care home (exp: n
= 1)
- Aphasia PwD (cont: n = 1)
- No demen(cid:2)a PwD (exp: n = 1, cont: n =
1)
- PwD wants to stop (exp, n = 2)
- Wants to stop (exp: n = 4, cont: n = 2)
Baseline (T0)
measurements
PwD (n = 38) & Dropout PwD (n = 12) due to:
IC (n = 35) - Admission into care home (exp: n = 4,
cont: n = 2)
- Died (cont: n = 1)
- Issues physical health (exp: n = 1)
- No demen(cid:2)a (exp: n = 1, cont: n = 1)
- Wants to stop (exp: n = 2)
Dropout IC (n = 15) due to:
- Admission PwD into care home (exp: n
= 5, cont: n = 1)
Died (cont: n = 1)
- PwD wants to stop (exp: n = 2) 3-month
- Wants to stop (exp: n = 5, cont: n=1) follow-up (T1)
PwD (n = 34) &
IC (n = 32)
Dropout PwD (n = 10) due to:
- Admission into care home (exp: n = 3,
cont: n = 1)
- Died (exp: n = 1, cont: n = 1)
- IC wants PwD to stop (exp: n = 2)
- Wants to stop (exp: n = 2)
Dropout IC (n = 20) due to:
- Admission PwD into care home (exp: n
= 2, cont: n = 3) 6-month
- Died (exp: n = 1, cont: n = 1) follow-up (T2)
- Issues physical health (exp: n = 1) PwD (n = 32) &
- Wants to stop (exp: n = 7, cont: n = 5) IC (n = 23)
Fig.1. Flowchartofdaycarecentersandparticipants.exp,exergaminggroup;cont,controlgroup;RCT,randomizedcontrolledtrial.
4 J.vanSantenetal./JAMDAxxx(2020)1e10
burden, quality of life, and positive care experiences. Background PwDand42ICsparticipatedatT2intheexergaminggroupand32
characteristicsofallPwDandICswerecollected.SeeTables2and3 PwDand23ICsinthecontrolgroup.Therewerenosignificantdif-
and Supplementary Material 1 (Supplementary Tables 1-3) for a ferences between PwD and ICs who dropped out and those who
completelistofoutcomemeasures. continued.
Table1showsbaselinecharacteristics.Therewerenostatistically
Procedures significant differences between the groups. PwD in the exergaming
groupweremorephysicallyactivethaninthecontrolgroup,butthis
Datawerecollected fromPwD via face-to-face interviewsat the difference was not significant. In the exergaming group, the mean
DCC, and ICs were interviewed by telephone at T0, T1, and T2. The (standarddeviation)ofminutesofexergamingduring1weekbythe
interviewers were bachelor’s or master’s students of (applied) psy- PwDwas32.4(39.2)atT0,22.8(24.7)atT1,and29.8(32.0)atT2.
chologyormedicine,whoreceivedextensivetraining.
PowerAnalysis PeopleWithDementia
The required sample size was based on one of the secondary Table 2 shows there were no effects on the primary outcome
outcomemeasures forcognitivefunctioning[Mini-Mental StateEx- measures for PwD. Effect sizes for mobility (Short Physical Perfor-
amination(MMSE)],becausenohigh-qualitystudiesinvestigatingthe manceBattery) weresmall (0.14at T1;0.11at T2,corrected forT0-
effect of a similar intervention on the primary outcomes (physical MMSE)andnotclinicallyrelevant.Addingotherconfoundershardly
activityandmobility)wereavailableatthattime.Assumingapowerof made any difference.Theeffect sizes for physical activity werealso
80% and a difference of 2 points (standard deviation of 4.6) on the small,butclinicallyrelevant(0.30atT1;0.28atT2,correctedonlyfor
MMSEwithanintraclustercorrelationcoefficientof0.05andanalpha T0-MMSE, and 0.35 at T1; 0.37 at T2 with the other potential con-
of 0.05, we needed a sample size of 166 dyads. When adding the foundersadded).
clustereffectof DCC(7 dyadspercluster) and dropout (4%),a total Regarding the secondary outcomes, 2 outcome measures for
sampleof224dyadswasneeded. cognitivefunctioningshowedpositiveeffectsofexergaming.Forthe
MMSE,thiswasatT2(r¼2.30,95%CI:0.65,3.96,P¼.007)witha
StatisticalAnalysis small,butclinicallyrelevant,effectsize(d¼0.36).Anothereffectwas
on the Trail Making Test part A (TMT-A) at T2 (r ¼ (cid:2)28.98, 95%
Analyses were performed using IBM SPSS, version 24.0 (IBM, CI:(cid:2)54.89,(cid:2)3.08,P¼.029)againwithasmall,butclinicallyrelevant,
Armonk, NY). To reveal any significant differences in background effect size (d ¼ (cid:2)0.37). Both effects (MMSE and TMT-A scores)
characteristics and dropout between the exergaming and control increasedslightlywhentheotherconfounderswereadded.
groups, independent samples t and c2 tests were performed on A third effect was found on the Behavior Observation Scale for
baselinedataforordinalandnominalvariables,respectively.Missing Intramural Psychogeriatrics [Gedragsobservatieschaal voor de Intra-
dataofalloutcomemeasureswereimputedonitemlevelaccordingto murale Psychogeriatrie (GIP)], subscale nonsocial behavior of the
theexistinginstructions. PwD.TherewasapositiveeffectofexergamingatT2whencorrected
Mixed-model (intention-to-treat) analyses were conducted with forT0-MMSE(r¼(cid:2)1.86,95%CI:(cid:2)3.56,(cid:2)0.17,P¼.031)withanalmost
time(3and6months),intervention(exergamingvscontrol),andthe mediumeffectsize(d¼(cid:2)0.49).Withtheotherconfoundersadded,
interactionbetweeninterventionandtime,toanalyzetheeffectson theeffectsizesremainedsmall((cid:2)0.26atT1ande0.34atT2).
alloutcomes.Allanalyseswereadjustedforthebaselinevalueofthe Amediumeffectsize((cid:2)0.53)wasfoundonthenumberoffallsat
particular outcome. A 3-level structure (ie, repeated observations T1infavorofexergaming.Otherclinicallyrelevanteffectsizeswereon
clustered within individuals and individuals clustered within DCC) cognitivefunctioning[TrailMakingTestpartB(TMT-B)],motivation
was used. This method adjusts for the correlation between the (IMIsubscales:1interest/enjoyment,4perceivedchoiceofphysical
repeated measurements within the individual. Additionally, dose- exercise),physicalactivities(PhysicalActivityScaleoftheElderly),and
response relationships were analyzed with the same method, with qualityoflifebothindicatedbythePwDthemselvesandbytheICs
exergamingasacontinuousvariable.Effectswereconsideredstatis- aboutthePwD(EQ-5D-5L).
ticallysignificantifP(cid:3).05.
Based on previous research, all mixed-model analyses were
adjustedforT0-MMSEasapotentialconfounder(T0-MMSE).Besides InformalCaregivers
that,additionaladjustmentsweremadeforbodymassindex(forthe
PwD), sex, age, and level of education (for both PwD and
ICs).34e36
Table3showstheeffectsforICs.Fordistressexperienceddueto
Furthermore, effect sizes (Cohen d) were calculated, with d (cid:4) 0.20 neuropsychiatric symptoms of the PwD (NPI-Q total distress) there
considereda small,d (cid:4)0.40amedium,andd (cid:4)0.80a largeeffect wasastatisticallysignificantpositiveeffectatT1whencorrectedfor
size.37Additionally,d(cid:4)0.24wasconsideredclinicallyrelevant,asat T0-MMSE(r¼(cid:2)3.30,95%CI:(cid:2)6.57,(cid:2)0.03,P¼.048)withasmall,but
this cutoff patients considered treatment clinically relevant.38 The clinically relevant effect size (d ¼ (cid:2)0.38). This effect becomes
samplesizewastoosmalltousethemethodofQUalitativeINteraction nonsignificantwhencorrectedfortheotherconfounders,buttheef-
Treesmentionedintheprotocol.39 fectsizeremainsclinicallyrelevant.Nosignificanteffectswerefound
ontheNPI-QtotaldistressatT2,andtheeffectsizesremainsmallbut
Results clinicallyrelevant.
Therewasapositiveeffectofexergamingonthesubjectiveburden
ParticipantFlowandBaselineMeasuresoftheStudyPopulation andsenseofcompetence(SSCQ)atT1whencorrectedforT0-MMSE
and the other confounders (r ¼ 2.78, 95% CI: 0.85, 4.71, P ¼.005)
Figure 1 showstheprocess of enrolment and allocation of DCCs withamediumeffectsize(d¼0.55).WhenonlyT0-MMSEofthePwD
and participants to the experimental and control groups, and the remainedasaconfounder,thiseffectsizewasstillsmallandclinically
reasonsfordrop-out.ElevenDCCsparticipatedintheexergamingand relevant(d¼0.35).ThiseffectdisappearedatT2.
9DCCsinthecontrolgroup.Intotal,112PwDandtheirICs(73exer- We did not find any dose-response effects (see Supplementary
gaming, 39 control) enrolled in the study. Because of drop-out, 52 Tables4and5).
J.vanSantenetal./JAMDAxxx(2020)1e10 5
Table1
BaselineCharacteristicsoftheStudyPopulation
Variables ExergamingGroup(n¼73) ControlGroup(n¼39) DifferenceBetweenGroups
TestStatistic(df) Pvalue
Peoplewithdementia(PwD)
Age,y,mean(SD) 79.0(6.0) 79.0(7.0) t(104)¼(cid:2)0.19 .99
Gender,n(%) c2(1)¼0.70 .40
Male 37(51) 23(59)
Female 36(49) 16(41)
Bodymassindex,mean(SD)* 28.0(4.7) 29.0(5.5) t(98)¼0.96 .34
Mini-MentalStateExaminationscore,mean(SD)y 18.1(6.7) 19.4(6.5) t(100)¼0.92 .36
Dementiatype,n(%) c2(4)¼2.76 .60
Alzheimer’s 25(34) 12(31)
Vascular 6(8) 3(8)
Mixed 3(4) 4(10)
Other 7(10) 6(15)
Unknown 32(44) 14(36)
Livingsituation,n(%) c2(3)¼0.63 .89
Independent,alone 15(21) 9(23)
Independent,withothers 50(68) 26(67)
Other 1(1) 0(0)
Unknown 7(10) 4(10)
Levelofeducation,n(%) c2(3)¼1.79 .62
Primaryeducationorless 15(21) 5(13)
Secondaryeducation 34(47) 17(44)
Highereducation 13(18) 10(26)
Unknown 11(15) 7(18)
Maritalstatus,n(%) c2(4)¼5.67 .23
Married/long-termcohabitation 52(71) 26(67)
Divorced 3(4) 0(0)
Unmarried 0(0) 2(5)
Widowed/partnerdeceased 12(16) 8(21)
Unknown 6(8) 3(8)
Experiencewithsports,n(%) 46(63) 24(62) c2(1)¼0.00 .98
Experiencewithcycling,n(%) 57(78) 33(85) c2(1)¼3.35 .07
Experiencewithtechnology,n(%) 27(37) 18(46) c2(1)¼1.19 .28
Experiencewithcomputergames,n(%) 12(16) 6(15) c2(1)¼0.00 .97
Informalcaregivers
Age,y,mean(SD) 65.0(13.0) 67.0(12.0) t(97)¼0.91 .37
Gender,n(%) c2(1)¼0.01 .94
Male 18(25) 10(26)
Female 54(74) 29(74)
Unknown 1(1) 0(0)
Levelofeducation,n(%) c2(3)¼3.58 .31
Primaryeducationorless 5(7) 0(0)
Secondaryeducation 32(44) 19(49)
Highereducation 24(33) 11(28)
Unknown 12(16) 9(23)
Maritalstatus,n(%) c2(3)¼0.66 .88
Married/long-termcohabitation 62(85) 33(85)
Unmarried 4(5) 2(5)
Widowed/partnerdeceased 1(1) 0(0)
Unknown 6(8) 4(0)
LivingtogetherwithPwD 42(58) 26(67) c2(1)¼1.62 .20
RelationshipwithPwD,n(%) c2(3)¼3.65 .30
Spouse 39(53) 26(67)
Son/daughter 22(30) 6(15)
Other 11(15) 7(18)
Unknown 1(1) 0(0)
*Forpeopleof70yearsorolder,abodymassindexbetween22and27.9isconsideredhealthy.
yScoresontheMini-MentalStateExaminationrangefrom0(severedementia)to30(nodementia).
Discussion thatis,whiletheICsdonotperformexergamingthemselves.Noim-
provementswerefoundonemotionalfunctioningofPwD,qualityof
This studyshows thatexergaming had no effect on the primary lifeofPwDandICs,orpositivecareexperiencesofICs.
outcomes.However,wedidobservesomesmalltomoderatepositive Previousresearchfoundpositiveeffectsofexergamingonphysical
effectsoncognitiveandsocialfunctioninginPwDandsmalleffectson activity,cognitiveandsocialfunctioning,andinterestorenjoymentin
distress and subjective burden and sense of competence of ICs. andperceivedchoiceofphysicalexerciseinPwD,whichisinlinewith
Furthermore, though not statistically significant, we did observe ourfindings.14,17,20,22,23Incontrastwithpreviousstudies,wedidnot
clinically relevanteffect sizesonphysical activityof PwD,and their find statistically significant effects on physical and emotional func-
interestorenjoymentandperceivedchoiceofphysicalexercise.These tioningofthePwD.24,50Thismayhavebeencausedbydifferencesin
areimportantandpromisingresults.Thisisthefirststudytoshow outcomemeasures.Forexample,weusedsingleitemsofTheOlder
thatexergamingforPwDindirectlyalsohaspositiveeffectsfortheICs, Persons and Informal Caregivers Survey Minimum DataSet that
Table2
TestScoresontheDifferentOutcomesperTimePoint,Between-GroupEffects,andEffectSizesforPwD
OutcomeMeasures ExergamingGroup ControlGroup Effect,r(95%CI), EffectSize,Effect,r(95%CI), EffectSize,Adj.Effect, Adj.EffectAdj.Effect, Adj.Effect
PValue Cohend PValue Cohend r(95%CI), Size, r(95%CI), Size,
PValuey Cohendy PValuey Cohendy
T0 T1 T2 T0 T1 T2 T1 T1 T2 T2 T1 T1 T2 T2
Primaryoutcomes
SPPB,mean(SD), 7.0(2.4) 7.1(2.1) 7.6(2.2) 7.8(2.0) 7.2(2.2) 8.0(2.2) 0.30 0.14 0.15 0.11 0.24 0.07 .37 0.17
range0-12 ((cid:2)0.52,1.12), ((cid:2)0.71,1.01), ((cid:2)0.63,1.11), ((cid:2).55,1.28),
P¼.47 P¼.73 P¼.58 P¼.43
Physical 281.4(286.4)312.3(380.5)312.3(469.4)182.3(155.8)178.3(181.5)188.1(149.0)97.42 0.30 112.21 0.28 90.85 0.35 119.11 0.37
activitiesper ((cid:2)43.92,238.75), ((cid:2)30.51,254.93), ((cid:2)60.79,242.49), ((cid:2)35.48,273.71),
week,min, P¼.18 P¼.12 P¼.24 P¼.13
mean(SD)
Secondaryoutcomes
MMSE,mean(SD)z, 18.1(6.7) 17.1(6.5) 17.9(7.3) 19.4(6.5) 18.0(4.9) 17.0(5.9) 0.55((cid:2)1.04,2.14), 0.09 2.30(0.65,3.96), 0.36 0.97 0.15x 2.53 0.39x
range0-30 P¼.50 P¼.007* ((cid:2)0.78,2.72), (0.71,4.34),
P¼.28x P¼.007x**
TMT-Ainseconds, 146.1(80.4) 145.0(81.0) 140.2(82.8) 121.2(70.7) 129.3(75.2) 136.8(79.4) (cid:2)9.21 (cid:2)0.12 (cid:2)28.98 (cid:2)0.37 (cid:2)19.15 (cid:2)0.24 (cid:2)29.96 (cid:2)0.38
mean(SD), ((cid:2)35.07,16.65), ((cid:2)54.89,(cid:2)3.08), ((cid:2)47.11,8.82), ((cid:2)57.47,(cid:2)2.44),
max300 P¼.48 P¼.029*** P¼.18 P¼.033****
TMT-Binseconds, 221.5(90.7) 224.5(88.9) 236.0(59.0) 224.8(77.7) 214.7(65.1) 223.1(70.9) 17.66 0.23 (cid:2)0.15 0.00 19.81 0.25 3.90 0.05
mean(SD), ((cid:2)23.37,58.69), ((cid:2)44.57,44.26), ((cid:2)26.40,66.01), ((cid:2)47.02,54.82),
max300 P¼.40 P¼1.00 P¼.40 P¼.88
ASCOT, 2(1) 2(1) 2(1) 2(1) 2(1) 2(1) (cid:2)0.01 (cid:2)0.01 (cid:2)0.72 (cid:2)0.09 (cid:2)0.07 (cid:2)0.09 (cid:2)0.10 (cid:2)0.13
mean(SD), ((cid:2)0.33,0.32), ((cid:2)0.41,0.27), ((cid:2)0.41,0.26), ((cid:2)0.45,0.25),
range1-4 P¼.96 P¼.68 P¼.67 P¼.58
IMI01,mean(SD), 13.8(9.8) 14.0(8.3) 12.2(7.0) 16.9(9.8) 17.5(10.8) 16.4(9.0) (cid:2)2.45 (cid:2)0.27 (cid:2)2.86((cid:2)6.56,0.83),(cid:2)0.31 (cid:2)0.51 (cid:2)0.06 (cid:2)3.06 (cid:2)0.33
rangefrom7-49 ((cid:2)5.98,1.08), P¼.13 ((cid:2)4.05,3.03), ((cid:2)6.74,0.62),
P¼.17 P¼.78 P¼.10
IMI02,mean(SD), 19.2(6.8) 19.4(6.7) 18.1(5.8) 21.0(6.9) 18.9(7.4) 20.0(7.7) 1.32 0.19 (cid:2)1.41((cid:2)4.26,1.45),(cid:2)0.21 1.22 0.18 (cid:2)0.80 (cid:2)0.12
range6-42 ((cid:2)1.39,4.03), P¼.33 ((cid:2)1.49,3.93), ((cid:2)3.64,2.05),
P¼.34 P¼.38 P¼.58
IMI03,mean(SD), 13.8(4.8) 13.5(4.4) 12.8(4.4) 14.0(4.8) 14.4(4.3) 12.4(3.3) (cid:2)0.59 (cid:2)0.13 (cid:2)0.01((cid:2)1.94,1.92), 0.00 (cid:2)0.27 (cid:2)0.06 0.19 0.04
range5-35 ((cid:2)2.40,1.22), P¼.99 ((cid:2)2.16,1.63), ((cid:2)1.84,2.21),
P¼.52 P¼.78 P¼.86
IMI04,mean(SD), 17.5(10.7) 18.2(10.8) 15.4(8.6) 17.2(9.2) 18.8(9.6) 18.8(9.0) (cid:2)0.50 (cid:2)0.05 (cid:2)3.51((cid:2)8.02,1.01),(cid:2)0.36 0.10 0.01 (cid:2)3.16 (cid:2)0.32
range7-49 ((cid:2)4.72,3.72), P¼.13 ((cid:2)4.37,4.57), ((cid:2)7.94,1.61),
P¼.82 P¼.97 P¼.19
IMI05,mean(SD), 5.9(3.6) 6.3(4.6) 5.5(4.8) 7.1(5.2) 6.2(4.0) 5.9(5.2) 0.46 0.1 0.12((cid:2)1.92,2.16), 0.03 0.94 0.21 1.09 0.25
range4-28 ((cid:2)1.44,2.37), P¼.91 ((cid:2)1.01,2.89), ((cid:2)1.00,3.19),
P¼.63 P¼.34 P¼.30
Psychological 60.0(10.2) 72.2(19.4) 75.1(23.0) 62.5(10.0) 75.9(15.6) 75.3(18.6) (cid:2)1.63 (cid:2)0.09 2.46((cid:2)4.17,9.09), 0.14 (cid:2)0.80 (cid:2)0.04 3.92 0.22
well-being, ((cid:2)8.00,4.74), P¼.47 ((cid:2)7.48,5.88), ((cid:2)3.05,10.89),
mean(SD), P¼.62 P¼.81 P¼.27
range5-100
PASE,mean(SD), 61.2(42.6) 46.0(37.0) 38.6(38.3) 57.3(43.2) 55.6(41.4) 52.0(43.8) (cid:2)9.16 (cid:2)0.22 (cid:2)12.71 (cid:2)0.31 (cid:2)5.84 (cid:2)0.14 (cid:2)4.75 (cid:2)0.12
range0-400 ((cid:2)23.67,5.34), ((cid:2)27.22,1.80), ((cid:2)21.92,10.24), ((cid:2)20.84,11.33),
P¼.22 P¼.09 P¼.48 P¼.56
GIP,mean(SD), 18.5(3.2) 18.2(3.8) 18.0(3.7) 19.2(4.4) 19.8(3.7) 21.0(4.0) (cid:2)0.86 (cid:2)0.23 (cid:2)1.86 (cid:2)0.49 (cid:2)0.97 (cid:2)0.26 (cid:2)1.28 (cid:2)0.34
rangefrom5-24 ((cid:2)2.77,1.05), ((cid:2)3.56,(cid:2)0.17), ((cid:2)3.04,1.09), ((cid:2)3.06,0.50),
P¼.37 P¼.031***** P¼.35 P¼.16
Numberoffalls, 2.5(2.8) 1.2(0.5) 1.5(0.8) 2.0(1.7) 2.0(1.0) 1.5(0.6) (cid:2)1.00 (cid:2)0.53 (cid:2)0.12 (cid:2)0.06 (cid:2)0.89 (cid:2)0.47 (cid:2)0.21 (cid:2)0.11
mean(SD), ((cid:2)3.71,1.70), ((cid:2)2.65,2.41), ((cid:2)3.92,2.13), ((cid:2)3.23,2.82),
during6 P¼.46 P¼.92 P¼.55 P¼.89
monthstrial
6
J.vanSantenetal./JAMDAxxx(2020)1e10
measures emotional functioning in general, whereas another study
usedmoredetailedandspecificinstrumentstomeasurefearoffalling
andconfidenceinbalance.50Thismayimplythattheeffectofexer-
gaming on emotional functioning is closely related to improved
physicalfunctioning.Inourstudy,wedidnotfindaneffectonphysical
functioning, which may explain the absence of effect in emotional
functioning.
For several outcomes, we found clinically relevant effect sizes,
although not statistically significant. This may be explained by the
small sample size, but also by the large variation in outcomes of
physicalactivityandmobility,physical,cognitive,emotionalandsocial
functioning,andqualityoflifeofthePwD.Withabiggersamplesize,
we could have conducted subgroup analysis. Furthermore, perhaps
theprescribedminimumoftwice-per-weekexergamingwastoolow
tofindstatisticallysignificanteffects.
Althoughtherewerenosignificantdifferencesincyclingexperi-
encebeforethestartofthestudybetweentheexergamingandcontrol
groups(seeTable1),PwDinthecontrolgroupdidtendtohavemore
cyclingexperience(P¼.07).Thismayhaveinfluencedtheoutcomes.
StrengthsandLimitations
ThefactthatmanyDCCsparticipated,thattherewasahighuptake
in study participants, and that they were enthusiastic about the
exergaming intervention are strengths of this study. Our study
showedthattheimplementationbytheorganizationassignedtothe
intervention group was successful. As we will report in a separate
article,theysystematicallyappliedstrategiesthatpositivelyinfluence
implementationfactorsattheleveloftheintervention,theusers(ie,
professionals), organization, and environment (J. van Santen et al,
unpublisheddata,2020).
However,thisstudyalsohadseverallimitations.Therecruitment
processwascomplicatedbymanyhinderingfactors,suchaslackof
moneyandtimeforDCCstoparticipateinthestudy,andICsalready
feelingoverburdened.Thisresultedinanunderpoweredsamplesize.
Additionally,manystatisticaltestswereperformed,whichcouldmean
thatsomeofthestatisticallysignificanteffectsareacoincidence.We
didnotcorrectformultipletesting,becausewedidnotfocussolelyon
statisticalsignificance,andalsofoundtheclinicalrelevanceofgreat
importance.51Nevertheless,tobeabletogeneralizeourfindingsto-
wardalargerpopulation,wethinkthestatisticallysignificanteffects
and clinically relevant effect sizes found in this study should be
confirmedinalargertrial.Additionally,therewasalargepercentage
ofdrop-outamongDCCs,PwD,andICs.
NooutcomedatawerecollectedaboutthestaffofDCCsactually
offeringtheintervention5timesperweekandencouragingresearch
participantstotakepartatleasttwiceperweekfor6months.Neither
wastheadherencerateofparticipantsmeasured.Moreover,interac-
tive cycling is only one type of exergaming and it is impossible to
verify whether the results are generalizable to other types of exer-
gaming.Anotherissuewithgeneralizabilityisselectionbias.Perhaps
DCCs, PwD,and ICs whowereinterestedinphysical activitieswere
moreinclinedtoparticipateinthestudy.
Some outcome measures may have been too complicated for
(some) PwD. The IMI, for example, has many statements with a 7-
point answering scale, which often confused PwD.44 Additionally,
certain outcome measures proved to be challenging when people
wereilliterate,deaf,ornotnativeDutchspeakers.Furthermore,the
numberofoutcomemeasurescausedlengthyinterviews((cid:4)1hour),
whichwasburdensome.DatawerealsocollectedbystaffofDCCsand
ICs using custom registration forms. This was regularly forgotten
(despitereminders)andledtomissingdataorerrors.Forsomeout-
comes,likethePhysicalActivityScaleoftheElderly,thereportingof
thePwDandICsdiffered,raisingquestionsaboutreliability.
90.0(cid:2)
20.0(cid:2)
03.0(cid:2)
80.0(cid:2)
01.0(cid:2)
30.0(cid:2)
72.0(cid:2)
70.0(cid:2)
)2.0(9.0
)2.0(8.0
)3.0(8.0
)2.0(8.0
)3.0(7.0
)3.0(7.0
,DwPL5-D5-QE
,)80.0,31.0(cid:2)(
,)10.0,81.0(cid:2)(
,)70.0,31.0(cid:2)(
,)20.0,71.0(cid:2)(
,)DS(naem
46.¼P
01.¼P
16.¼P
41.¼P
1-0egnar
52.0(cid:2)
70.0(cid:2)
10.0
00.0
42.0(cid:2)
70.0(cid:2)
10.0
00.0
)3.0(5.0
)2.0(5.0
)3.0(5.0
)3.0(5.0
)3.0(5.0
)3.0(4.0
,DwP_CIL5-D5-QE
,)50.0,91.0(cid:2)(
,)11.0,11.0(cid:2)(
,)40.0,81.0(cid:2)(
,)11.0,01.0(cid:2)(
,)DS(naem
52.¼P
89.¼P
32.¼P
69.¼P
1-0egnar
eriannoitseuqsnoisnemid5loQoruEehtgnisu,flesrehroflesmihybdetacidnisaaitnemedhtiwtnapicitrapehtfoefilfoytilauq,DwPL5-D5-QE;xednissamydob,IMB;54tiklooTsemoctuOeraClaicoStludA,TOCSA;detsujda,.jdA lamrofnirehrosihybdetacidnisaaitnemedhtiwtnapicitrapehtfoefilfoytilauq,DwP_CIL5-D5-QE;)64tneipicereracSDM-SCIPOT(teSataDmuminiMyevruSsrevigeraClamrofnIdnasnosrePredlOehTmorf74elacslevel-5htiw rofelacSnoitavresbOroivaheB,PIG;)64tneipicereracSDM-SCIPOT(teSataDmuminiMyevruSsrevigeraClamrofnIdnasnosrePredlOehTmorf74elacslevel-5htiweriannoitseuqsnoisnemid5loQoruEehtgnisu,revigerac ,20IMI;esicrexelacisyhpnitnemyojne/tseretni1elacsbus,24yrotnevnInoitavitoMcisnirtnI,10IMI;15retneceracyadehtniaitnemedhtiwgniviltnapicitrapehtfogninoitcnuflaicoS1elacsbus:scirtairegohcysPlarumartnI 4elacsbus,yrotnevnInoitavitoMcisnirtnI,40IMI;esicrexelacisyhpfoecnatropmi/nitroffe3elacsbus,yrotnevnInoitavitoMcisnirtnI,30IMI;esicrexelacisyhpniecnetepmocdeviecrep2elacsbus,yrotnevnInoitavitoMcisnirtnI morfgninoitcnuflanoitome,gnieb-llewlacigolohcysP;34ylredlEehtfoelacSytivitcAlacisyhP,ESAP;esicrexelacisyhpfossenlufesu/eulav5elacsbus,yrotnevnInoitavitoMcisnirtnI,50IMI;esicrexelacisyhpfoeciohcdeviecrep
44.BtraptseTgnikaMliarT,B-TMT;AtraptseTgnikaMliarT,A-TMT;23yrettaBecnamrofrePlacisyhPtrohS,BPPS;)64tneipicereracSDM-SCIPOT(teSataDmuminiMyevruSsrevigeraClamrofnIdnasnosrePredlOehT
.rednuofnocasaDwPehtfo43ESMMehtno)0T(erocsenilesabehthtiwerasemoctuO.evitisoperomeraserocsdenilrednU
retfapuorglortnocehtotderapmocpuorggnimagrexeehtnierocsESMMehtniesaercnitnacfiingisyllacitsitatsadewohsemitdnanoitnevretnineewtebnoitcaretniehtdna)shtnom6(emithtiwsisylanaledom-dexiM*
.shtnom6
retfapuorglortnocehtotderapmocpuorggnimagrexeehtnierocsESMMehtniesaercnitnacfiingisyllacitsitatsadewohsemitdnanoitnevretnineewtebnoitcaretniehtdna)shtnom6(emithtiwsisylanaledom-dexiM**
.srednuofnocsaDwPehtfonoitacudefoleveldna,ega,xes,IMBrofdetcerrocnehw,shtnom6
retfapuorglortnocehtotderapmocpuorggnimagrexeehtnierocsA-TMTehtninoitcudertnacfiingisyllacitsitatsadewohsemitdnanoitnevretnineewtebnoitcaretniehtdna)shtnom6(emithtiwsisylanaledom-dexiM***
.rednuofnocasaDwPehtfoESMMehtno)0T(erocsenilesabehtrofdetcerrocnehw,shtnom6
retfapuorglortnocehtotderapmocpuorggnimagrexeehtnierocsA-TMTehtninoitcudertnacfiingisyllacitsitatsadewohsemitdnanoitnevretnineewtebnoitcaretniehtdna)shtnom6(emithtiwsisylanaledom-dexiM****
.srednuofnocsaDwPehtfonoitacudefoleveldna,ega,xes,IMB,ESMMehtno)0T(erocsenilesabehtrofdetcerrocnehw,shtnom6
retfapuorglortnocehtotderapmocpuorggnimagrexeehtnierocsPIGehtninoitcudertnacfiingisyllacitsitatsadewohsemitdnanoitnevretnineewtebnoitcaretniehtdna)shtnom6(emithtiwsisylanaledom-dexiM*****
.rednuofnocasaDwPehtfoESMMehtno)0T(erocsenilesabehtrofdetcerrocnehw,shtnom6
.DwPehtfonoitacudefoleveldna,ega,xes,IMB,ESMMehtno)0T(erocsenilesab:selbairavgnidnuofnocrofdetsujdaserocsemoctuOy
.srednuofnocynatuohtiwerasemoctuOz
.DwPehtfonoitacudefoleveldna,ega,xes,IMB:selbairavgnidnuofnocrofdetsujdaserocsemoctuOx
J.vanSantenetal./JAMDAxxx(2020)1e10 7
Table3
TestScoresontheDifferentOutcomesperTimePointandBetween-GroupEffectsforIC
OutcomeMeasures ExergamingGroup ControlGroup Effect, EffectSize, Effect, EffectSize, Adj.Effect, Adj.Effect Adj.Effect, Adj.Effect
r(95%CI), Cohend r(95%CI), Cohend r(95%CI), Size,Cohendy r(95%CI), Size,
PValue PValue PValuey PValuey Cohendy
T0 T1 T2 T0 T1 T2 T1 T1 T2 T2 T1 T1 T2 T2
EQ-5D-5LIC, 0.9(0.1) 0.8(0.2) 0.9(0.2) 0.8(0.2) 0.8(0.2) 0.8(0.2) (cid:2)0.00 (cid:2)0.02 (cid:2)0.00 0.00 0.00 0.01 (cid:2)0.01 (cid:2)0.04
mean(SD), ((cid:2)0.07,0.07), ((cid:2)0.07,0.07), ((cid:2)0.07,0.08), ((cid:2)0.09,0.08),
range0-1 P¼.90 P¼.90 P¼.95 P¼.86
CarerQoL, 81.0(16.0) 81.0(15.0) 83.0(12.0) 79.0(16.0) 78.0(15.0) 76.0(18.0) 0.06 0.00 3.16 0.21 (cid:2)0.17 (cid:2)0.01 3.58 0.23
mean(SD), ((cid:2)5.55,5.67), ((cid:2)2.92,9.23), ((cid:2)5.85,5.51), ((cid:2)2.55,9.72),
range0-100 P¼.98 P¼.31 P¼.95 P¼.25
NPI-Qtotal 10.6(6.3) 9.5(6.8) 7.3(6.3) 8.4(5.5) 8.9(6.9) 7.6(4.8) (cid:2)0.44 (cid:2)0.07 (cid:2)0.98 (cid:2)0.15 (cid:2)0.48 (cid:2)0.08 (cid:2)1.30 (cid:2)0.21
severity ((cid:2)2.83,1.95), ((cid:2)3.65,1.69), ((cid:2)3.00,2.04), ((cid:2)4.09,1.49),
ofsymptoms, P¼.72 P¼.47 P¼.71 P¼.36
mean(SD),
range0-36
NPI-Qtotal 12.3(9.0) 9.9(9.4) 8.2(8.0) 9.3(7.8) 11.8(9.7) 10.3(7.3) (cid:2)3.30 (cid:2)0.38 (cid:2)3.09 (cid:2)0.35 (cid:2)3.05 0.35 (cid:2)3.18 (cid:2)0.36
distress, ((cid:2)6.57,(cid:2)0.03), ((cid:2)6.74,0.57), ((cid:2)6.48,0.38), ((cid:2)6.98,0.63),
mean(SD), P¼.048* P¼.10 P¼.08 P¼.10
range0-60
NPI-Qtotal 5.9(3.6) 7.0(4.0) 7.4(4.4) 5.9(3.8) 6.6(4.2) 7.2(4.5) 0.16 0.04 (cid:2)0.24 (cid:2)0.06 0.18 0.04 (cid:2)0.47 (cid:2)0.12
numberof ((cid:2)1.26,1.58), ((cid:2)1.67,1.18), ((cid:2)1.33,1.70), ((cid:2)1.99,1.05),
symptoms, P¼.83 P¼.74 P¼.81 P¼.54
mean(SD),
range0-12
SSCQ, 26.9(4.9) 27.7(5.0) 27.2(5.1) 26.3(5.5) 26.1(5.3) 27.5(4.5) 1.75 0.35 (cid:2)1.21 (cid:2)0.24 2.78 0.55 (cid:2)0.84 (cid:2)0.17
mean(SD), ((cid:2)0.19,3.69), ((cid:2)3.35,0.93), (0.85,4.71), ((cid:2)2.98,1.30),
range7-35 P¼.08 P¼.27 P¼.005** P¼.44
PES, 4.8(1.8) 4.9(1.7) 5.1(1.5) 4.8(2.1) 4.6(2.2) 5.0(2.4) 0.23 0.12 0.09 0.05 0.24 0.13 0.13 0.07
mean(SD), ((cid:2)0.38,0.84), ((cid:2)0.58,0.75), ((cid:2)0.40,0.88), ((cid:2)0.58,0.84),
range0-8 P¼.46 P¼.80 P¼.46 P¼.72
Adj.,adjusted;CarerQoL,qualityoflifeoftheinformalcaregiverusingtheCare-relatedQualityofLifeinstrumentfromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScaregiver46);EQ-5D-5L
IC,qualityoflifeoftheinformalcaregiverusingtheEuroQol5dimensionsquestionnairewith5-levelscalefromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScarerecipient);NPI-Qtotal
severityofsymptoms,totalseverityofsymptomsusingtheNeuropsychiatricInventoryeQuestionnaire48;NPI-Qtotaldistress,totalamountofdistresscausedbythesymptomsasexperiencedbytheinformalcaregiverusingthe
NeuropsychiatricInventoryeQuestionnaire;NPI-Qtotalnumberofsymptoms,totalnumberofsymptomsusingtheNeuropsychiatricInventoryeQuestionnaire;PES,positivecareexperiencesoftheinformalcaregiverusing
ScaleofPositiveExperiences[inDutch:PositieveErvaringenSchaal50];SSCQ,subjectiveburdenfortheinformalcaregiverusingtheShortSenseofCompetenceQuestionnaire.49
Underlinedscoresaremorepositive.Outcomesarewiththebaselinescore(T0)ontheMMSE34ofthePwDasaconfounder.
*Mixed-modelanalysiswithtime(3months)andtheinteractionbetweeninterventionandtimeshowedastatisticallysignificantreductionintheNPI-Qtotaldistressscoreintheexergaminggroupcomparedtothecontrol
groupafter3months,whencorrectedforthebaselinescore(T0)ontheMMSEofthePwDasaconfounder.
**Mixed-modelanalysiswithtime(3months)andtheinteractionbetweeninterventionandtimeshowedastatisticallysignificantincreaseintheSSCQscoreintheexergaminggroupcomparedtothecontrolgroupafter
3months,whencorrectedforthebaselinescore(T0)ontheMMSEofthePwDandsex,age,andlevelofeducationoftheICasconfounders.
yOutcomescoresadjustedforconfoundingvariables:baselinescore(T0)ontheMMSEofthePwDandsex,age,andlevelofeducationoftheIC.
8
J.vanSantenetal./JAMDAxxx(2020)1e10
J.vanSantenetal./JAMDAxxx(2020)1e10 9
ConclusionsandImplications 16. StaianoAE,FlynnR.Therapeuticusesofactivevideogames:Asystematicre-
view.GamesHealthJ2014;3:351e365.
17. vanSantenJ,DröesRM,HolstegeM,etal.Effectsofexergaminginpeoplewith
Despitealackofpowerinourstudy,wewouldrecommend(staff
dementia:Resultsofasystematicliteraturereview.JAlzheimersDis2018;64:
of) care organizations to offer exergaming to PwD. Ways to obtain 741e760.
funding for the equipment would need to be explored as this was 18. HeuvelinkA,GrootJ,Hofstede-KleywegC.Let’splay:stimulateolderpeopleto
movewithappliedgames.Ede:CoalitieAppliedGamingforHealthyAging;
sometimes a problem for DCCs. Our recommendation to offerexer-
TNO;VitaValley;2014-01-012014.
gamingisbasedonthepositiveeffectsoncognitiveandsocialfunc- 19. MeekesW,StanmoreEK.Motivationaldeterminantsofexergameparticipation
tioningofthePwDandondistressandsenseofcompetenceoftheir for older people in assisted living facilities: Mixed-methods study. J Med
InternetRes2017;19:e238.
carersandthelackofadverseevents.Communicationoftheseresults
20. UnbehaunD,VaziriDD,AalK,etal.Exploringthepotentialofexergamesto
mayencouragePwDtoexercisemoreandtoexperiencethebenefits.
affectthesocialanddailylifeofpeoplewithdementiaandtheircaregivers.
Based on this study, this canbe expectedtoindirectly benefit their Paperpresentedat:The2018CHIConferenceonHumanFactorsinComputing
carers’senseofcompetence,subjectiveburden,anddistress.Future Systems;2018.Montreal,QC,Canada.
21. Anderson-HanleyC,ArcieroPJ,BrickmanAM,etal.Exergamingandolderadult
studieswithlargersamplesarerecommendedtoconfirmourfindings
cognition: A cluster randomized clinical trial. Am J Prev Med 2012;42:
andtoextendtheknowledgeabouttheeffectivenessofdifferenttypes 109e119.
ofexergamingindifferentsettings. 22. WernerC,RosnerR,WilothS,etal.Timecourseofchangesinmotor-cognitive
exergame performances during task-specific training in patients with de-
mentia: Identificationand predictorsofearlytrainingresponse. JNeuroeng
Acknowledgments Rehabil2018;15:100.
23. KarssemeijerEGA,AaronsonJA,BossersWJR,etal.Thequestforsynergybe-
tweenphysicalexerciseandcognitivestimulationviaexergaminginpeople
WewouldliketothankSjefvanBommel(SjefvanBommelMan- withdementia:Arandomizedcontrolledtrial.AlzheimersResTher2019;11:3.
agement&Support),JudithBosmans(VrijeUniversiteitAmsterdam), 24. BurdeaG,PolisticoK,KrishnamoorthyA,etal.FeasibilitystudyoftheBright-
EstherHakvoort(Evean),MarijeHolstege(GRZPlus),CarlaScholten
Brainer(cid:3)integrativecognitiverehabilitationsystemforelderlywithdementia.
DisabilRehabilAssistTechnol2015;10:421e432.
(Embedded Fitness), Marian Schoone (TNO), Marjolein Smit (Silver-
25. ShimSH,KangHS,KimJH,KimDK.Factorsassociatedwithcaregiverburdenin
Fit),RonaldValk(HilverZorg),andJorisWiersinga(SilverFit)fortheir dementia:1-yearfollow-upstudy.PsychiatryInvestig2016;13:43e49.
contributionsasprojectgroupmembers.Additionally,wewouldlike 26. CrossAJ,GaripG,SheffieldD.Thepsychosocialimpactofcaregivinginde-
mentiaandqualityoflife:Asystematicreviewandmeta-synthesisofquali-
tothankthemembersofourAdvisoryCommittee:ConchitaHofstede tativeresearch.PsycholHealth2018;33:1321e1342.
(Nictiz),ThedvanKempen(StichtingGroenhuysen),MartinKrommert 27. Isik AT, Soysal P, Solmi M, Veronese N. Bidirectional relationship between
(ArgosZorggroep),and Jeroen Olthof(MunicipalityofZaandam)for caregiverburdenandneuropsychiatricsymptomsinpatientswithAlzheimer’s
theircontributionstotheprojectandAnneliesvanRijn(Saffier)for
disease:Anarrativereview.IntJGeriatrPsychiatry2019;34:1326e1334.
28. SchurD,WhitlatchCJ.Circumstancesleadingtoplacement:Adifficultcare-
providingpracticalsupportthroughouttheprocessofobtainingMETc givingdecision.LippincottsCaseManage2003;8:187e195.
approval. 29. StowellE,ZhangY,Castaneda-SceppaC,etal.CaringforAlzheimer’sdisease
caregivers: A qualitative study investigating opportunities for exergame
innovation.ProcACMHum-ComputInteract2019;3:1e27.
References 30. SaghaeiM.Randomallocationsoftwareforparallelgrouprandomizedtrials.
BMCMedResMethodol2004;4:26.
1. PenedoFJ,DahnJR.Exerciseandwell-being:Areviewofmentalandphysical 31. vanSantenJ,DröesRM,BosmansJE,etal.The(cost-)effectivenessofexer-
healthbenefitsassociatedwithphysicalactivity.CurrOpinPsychiatry2005;18: gaminginpeoplelivingwithdementiaandtheirinformalcaregivers:Protocol
189e193. forarandomizedcontrolledtrial.BMCGeriatr2019;19:50.
2. BlondellSJ,Hammersley-MatherR,VeermanJL.Doesphysicalactivityprevent 32. Guralnik JM, Simonsick EM, Ferrucci L, et al. A Short Physical Performance
cognitive decline and dementia? A systematic review and meta-analysis of Battery assessing lower extremity function: Association with self-reported
longitudinalstudies.BMCPublicHealth2014;14:510. disabilityandpredictionofmortalityandnursinghomeadmission.JGerontol
3. TaylorAH,CableNT,FaulknerG,etal.Physicalactivityandolderadults:A 1994;49:M85eM94.
reviewofhealthbenefitsandtheeffectivenessofinterventions.JSportsSci 33. VasunilashornS,CoppinAK,PatelKV,etal.UseoftheShortPhysicalPerfor-
2004;22:703e725. manceBatteryScoretopredictlossofabilitytowalk400meters:Analysisfrom
4. PitkäläK,SavikkoN,PoystiM,etal.Efficacyofphysicalexerciseintervention theInCHIANTIstudy.JGerontolABiolSciMedSci2009;64:223e229.
onmobilityandphysicalfunctioninginolderpeoplewithdementia:Asys- 34. Cockrell J, Folstein MF. Mini Mental State Examination (MMSE). Psycho-
tematicreview.ExpGerontol2013;48:85e93. pharmacolBull1988;24:689e692.
5. PotterR,EllardD,ReesK,ThorogoodM.Asystematicreviewoftheeffectsof 35. Ferretti MT, Iulita MF, Cavedo E, et al. Sex differences in Alzheimer dis-
physicalactivityonphysicalfunctioning,qualityoflifeanddepressioninolder easedThegatewaytoprecisionmedicine.NatRevNeurol2018;14:457e469.
peoplewithdementia.IntJGeriatrPsychiatry2011;26:1000e1011. 36. BretelerMMB,SchrijversEMC.Epidemiologie.In:JonkerC,SlaetsJPJ,VerheyFRJ,
6. HeynP,AbreuBC,OttenbacherKJ.Theeffectsofexercisetrainingonelderly editors. Handbook on Dementia: Latest insights in Diagnosis and Treatment.
personswithcognitiveimpairmentanddementia:Ameta-analysis.ArchPhys Houten,theNetherlands:BohnStafleuvanLoghum;2009.p.13e22.
MedRehabil2004;85:1694e1704. 37. SawilowskySS.Neweffectsizerulesofthumb.JModernApplStatMethods
7. vanAlphenHJM,HortobágyiT,vanHeuvelenMJG.Barriers,motivators,and 2009;8:26.
facilitatorsofphysicalactivityindementiapatients:Asystematicreview.Arch 38. CuijpersP,TurnerE,KooleS,etal.Whatisthethresholdforaclinicallyrelevant
GerontolGeriatr2016;66:109e118. effect? The case of major depressive disorders. Depress Anxiety 2014;31:
8. NymanSR.Psychosocialissuesinengagingolderpeoplewithphysicalactivity 374e378.
interventionsforthepreventionoffalls.CanJAging2011;30:45e55. 39. Dusseldorp E, Van Mechelen I. Qualitative interaction trees: A tool to
9. CrombieIK,IrvineL,WilliamsB,etal.Whyolderpeopledonotparticipatein identify qualitative treatmentesubgroup interactions. Stat Med 2014;33:
leisuretimephysicalactivity:Asurveyofactivitylevels,beliefsanddeterrents. 219e237.
AgeAgeing2004;33:287e292. 40. vanLeeuwenKM,BosmansJE,JansenAP,etal.Dutchtranslationandcross-
10. ClarkeDE,vanReekumR,SimardM,etal.Apathyindementia:Clinicaland culturalvalidationoftheAdultSocialCareOutcomesToolkit(ASCOT).Health
sociodemographic correlates. J Neuropsychiatry Clin Neurosci 2008;20: QualLifeOutcomes2015;13:56.
337e347. 41. HerdmanM,GudexC,LloydA,etal.Developmentandpreliminarytestingof
11. BinnekadeT,EggermontL,ScherderE.Unmovedaboutmovement:Physical the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:
(in) activity in care institutions. VU University, Dept. of Clinical Neuropsy- 1727e1736.
chology,Amsterdam;2012. 42. vandenBrinkD,LutomskiJE,QinL,etal.TOPICS-MDS:Veelzijdigebronvoor
12. Anderiesen H, Scherder EJA, Goossens RHM, Sonneveld MH. A systematic wetenschappelijkeenmaatschappelijkekennisgeneratietenbehoevevande
reviewdphysical activity in dementia: The influence of the nursing home ouderenzorg.TijdschrGerontolGeriatr2015;46:78e91.
environment.ApplErgon2014;45:1678e1686. 43. VerstratenPFJ,VanEekelenCWJM.ManualfortheGIP:BehaviouralObserva-
13. Sun F,NormanIJ,WhileAE.Physicalactivity inolderpeople: Asystematic tion Scale for Intramural Psychogeriatrics. Deventer, the Netherlands: Van
review.BMCPublicHealth2013;13:449. LoghumSlaterus;1987.
14. MuraG,CartaMG,SancassianiF,etal.Activeexergamestoimprovecognitive 44. DeciEL,EghrariH,PatrickBC,LeoneDR.Facilitatinginternalization:Theself-
functioninginneurologicaldisabilities:Asystematicreviewandmeta-analysis. determinationtheoryperspective.JPers1994;62:119e142.
EurJPhysRehabilMed2018;54:450e462. 45. WashburnRA,SmithKW,JetteAM,JanneyCA.Thephysicalactivityscalefor
15. Sun H. Exergaming impact on physical activity and interest in elementary the elderly (PASE): Development and evaluation. J Clin Epidemiol 1993;46:
schoolchildren.ResQExercSport2012;83:212e220. 153e162.
10 J.vanSantenetal./JAMDAxxx(2020)1e10
46. Ashendorf L, Jefferson AL, O’Connor MK, et al. Trail Making Test errors in 49. Vernooij-Dassen MJFJ, Felling AJA, Brummelkamp E, et al. Assessment of
normal aging, mild cognitive impairment, and dementia. Arch Clin Neuro- caregiver’scompetenceindealingwiththeburdenofcaregivingforadementia
psychol2008;23:129e137. patient:AShortSenseofCompetence(SSCQ)suitableforclinicalpractice.JAm
47. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: GeriatrSoc1999;47:256e257.
Comprehensiveassessmentofpsychopathologyindementia.Neurology1994; 50. PadalaKP,PadalaPR,LensingSY,etal.Home-basedexerciseprogramimproves
44:2308. balance and fear of falling in community-dwelling older adults with mild
48. deBoerAH,OudijkD,vanGroenouMIB,TimmermansJM.Positiveexperiences Alzheimer’sdisease:Apilotstudy.JAlzheimersDis2017;59:565e574.
throughinformalcare:Constructionofascale.TijdschrGerontolGeriatr2012; 51. WassersteinRL,SchirmAL,LazarNA.Movingtoaworldbeyond“p<0.05”.Am
43:243e254. Stat2019;73:1e19.
J.vanSantenetal./JAMDAxxx(2020)1e10 10.e1
SupplementaryTable1
SecondaryOutcomeMeasuresforParticipantsLivingWithDementia
Outcome OutcomeMeasure RecordedBy Timing
Baseline 3mo 6mo
Physicalfunctioning PhysicalActivityScaleoftheElderly(PASE)45 Researcherduringinterview X X X
Cognitivefunctioning Mini-MentalStateExamination(MMSE)34 Researcherbymeansoftest X X X
Cognitivefunctioning TrailMakingTest(TMT)46 Researcherbymeansoftest X X X
Socialfunctioning OnequestionfromtheAdultSocial Researcherduringinterview X X X
CareOutcomesToolkit(ASCOT)40
Demographicsandpersonalcharacteristics TheOlderPersonsandInformal Researcherduringinterview X X X
Physicalfunctioning CaregiversSurveyMinimum
Cognitivefunctioning DataSet(TOPICS-MDScarerecipient),42
Socialfunctioning includingEuroQol5dimensions
Emotionalfunctioning questionnairewith5-levelscale(EQ-5D-5L)41
Qualityoflife
Interestinandenjoymentofphysicalexercise IntrinsicMotivationInventory(IMI)44 Researcherduringinterview X X X
Bodymassindex(BMI) Weightscaleandmeasuringtapetomeasureheight Researcherduringinterview X
TMT-A,TrailMakingTestpartA;TMT-B,TrailMakingTestpartB.
SupplementaryTable2
SecondaryOutcomeMeasuresforParticipantsLivingWithDementiaandInformalCaregiversAnsweredbyInformalCaregivers
Outcome OutcomeMeasure RecordedBy Timing
Baseline 3mo 6mo 0-6mo
(Ongoing)
Physicalfunctioningoftheparticipantlivingwith PhysicalActivityScaleoftheElderly(PASE)45 Researcherduringinterview X X X
dementia
Fallincidentrateoftheparticipantwithdementia Customregistrationform Informalcaregiver X X X
duringthepast3mo
Behaviorandmoodoftheparticipantlivingwith NeuropsychiatricInventoryeQuestionnaire Researcherduringinterview X X X
dementia (NPI-Q)47
Emotionalburdenfortheinformalcaregiver
Forbothinformalcaregiverandparticipantwith TheOlderPersonsandInformalCaregiversSurvey Researcherduringinterview X X X
dementia: MinimumDataSet(TOPICS-MDSinformal
Demographicsandpersonalcharacteristics caregiver)42includingEuroQol5dimensions
Physicalfunctioning questionnairewith5-levelscale(EQ-5D-5L)41
Cognitivefunctioning
Socialfunctioning
Emotionalfunctioning
Qualityoflife
Experiencesoftheinformalcaregiver
Subjectiveburdenfortheinformalcaregiver ShortSenseofCompetenceQuestionnaire(SSCQ)49 Researcherduringinterview X X X
Positivecareexperiencesoftheinformalcaregiver ScaleofPositiveExperiences(PositieveErvaringen Researcherduringinterview X X X
Schaal(PES))48
Unexpected(Adverse)Events, (Care)diaries(1fortheparticipantlivingwith Informalcaregiver X
fallsandreasonsof(potential)dropout dementia,1fortheinformalcaregiver)
Experienceoftheparticipantliving Separatequestions Researcherduringinterview X
withdementiawithsportsorcycling,
technologyanddigitalgamesinthepast
10.e2 J.vanSantenetal./JAMDAxxx(2020)1e10
SupplementaryTable3
SecondaryOutcomeMeasuresforParticipantsLivingWithDementiaAnsweredbyStaffoftheDayCareCenters
Outcome OutcomeMeasure RecordedBy Timing
Baseline 3mo 6mo
Fallincidentrateoftheparticipantwithdementia Customregistrationform Staffatdaycarecenter X X X
duringthepast3mo
Socialfunctioningoftheparticipantlivingwith GIP:BehaviorObservationScaleforIntramural Staffatdaycarecenter X X X
dementiainthedaycarecenter Psychogeriatrics:subscale1(unsocialbehavior)
[GedragsobservatieschaalvoordeIntramurale
Psychogeriatrie(GIP):subschaal1]43
SupplementaryTable4
TestScoresontheDifferentOutcomesperTimePoint,Dose-ResponseEffects,andEffectSizesforPwD
OutcomeMeasures ExergamingGroup Dose-Response EffectSize, Dose-Response EffectSize, Adj.Dose-Response Adj.Effect Adj.Dose-Response Adj.Effect
Effect*,r(95%CI), Cohend Effect*,r(95%CI), Cohend Effect*,r(95%CI),PValuey Size, Effect*,r(95%CI), Size,
PValue PValue Cohendy PValuey Cohendy
T0 T1 T2 T1 T1 T2 T2 T1 T1 T2 T2
Primaryoutcomes
SPPB,mean(SD), 7.0(2.4) 7.1(2.1) 7.6(2.2) 0.01((cid:2)0.12,0.22),P¼.55 0.02 0.05((cid:2)0.01,0.02),P¼.51 0.02 0.00((cid:2)0.01,0.02),P¼.71 0.01 0.01 0.03
range0-12 ((cid:2)0.01,0.02),
P¼.42
Physicalactivities 281.4(286.4) 312.3(380.5) 312.3(469.4) 1.98((cid:2)0.12,4.07),P¼.07 0.06 1.55((cid:2)0.09,3.18),P¼.06 0.05 1.94((cid:2)0.26,4.14),P¼.08 0.06 1.62 0.05
perweek, ((cid:2)0.12,3.36),
min,mean(SD) P¼.07
Secondaryoutcomes
MMSE, 18.1(6.7) 17.1(6.5) 17.9(7.3) (cid:2)0.01((cid:2)0.04,0.03),P¼.73 (cid:2)0.01 0.00((cid:2)0.03,0.02),P¼.73 (cid:2)0.01 0.00((cid:2)0.04,0.03),P¼.95x 0.00x (cid:2)0.01 (cid:2)0.01x
mean(SD)z, ((cid:2)0.03,0.02),
range0-30 P¼.70x
TMT-A,s, 146.1(80.4) 145.0(81.0) 140.2(82.8) (cid:2)0.07((cid:2)0.58,0.43),P¼.78 (cid:2)0.01 (cid:2)0.23(-0.72,0.27),P¼.37 (cid:2)0.03 (cid:2)0.12((cid:2)0.65,0.40),P¼.65 (cid:2)0.02 (cid:2)0.27 (cid:2)0.03
mean(SD), ((cid:2)0.79,0.25),
max300 P¼.31
TMT-B,s, 221.5(90.7) 224.5(88.9) 236.0(59.0) 0.66((cid:2)0.05,1.38),P¼.07 0.09 0.31((cid:2)0.56,1.17),P¼.48 0.04 0.67((cid:2)0.09,1.43),P¼.08 0.09 0.42 0.05
mean(SD), ((cid:2)0.50,1.33),
max300 P¼.37
ASCOT, 2(1) 2(1) 2(1) 0.00((cid:2)0.01,0.01),P¼.58 0.03 0.00((cid:2)0.01,0.00),P¼.42 (cid:2)0.03 0.00((cid:2)0.01,0.01),P¼.53 0.03 0.00 (cid:2)0.03
mean(SD), ((cid:2)0.01,0.00),
range1-4 P¼.42
IMI01, 13.8(9.8) 14.0(8.3) 12.2(7.0) (cid:2)0.02((cid:2)0.10,0.06),P¼.62 (cid:2)0.02 (cid:2)0.02((cid:2)0.08,0.05),P¼.57 (cid:2)0.02 0.00((cid:2)0.07,0.08),P¼.93 0.00 (cid:2)0.02 (cid:2)0.02
mean(SD), ((cid:2)0.08,0.04),
rangefrom7-49 P¼.48
IMI02, 19.2(6.8) 19.4(6.7) 18.1(5.8) 0.01((cid:2)0.05,0.08),P¼.66 0.02 (cid:2)0.01(-0.06,0.04),P¼.58 (cid:2)0.02 0.01((cid:2)0.05,0.07),P¼.72 0.02 (cid:2)0.01 (cid:2)0.02
mean(SD), ((cid:2)0.06,0.04),
range6-42 P¼.66
IMI03, 13.8(4.8) 13.5(4.4) 12.8(4.4) (cid:2)0.02((cid:2)0.06,0.03),P¼.44 (cid:2)0.04 (cid:2)0.01(-0.05,0.02),P¼.47 (cid:2)0.03 (cid:2)0.02((cid:2)0.06,0.02),P¼.30 (cid:2)0.05 (cid:2)0.01 (cid:2)0.03
mean(SD), ((cid:2)0.05,0.02),
range5-35 P¼.41
IMI04, 17.5(10.7) 18.2(10.8) 15.4(8.6) 0.03((cid:2)0.07,0.13),P¼.50 0.03 (cid:2)0.04((cid:2)0.12,0.04),P¼.33 (cid:2)0.04 0.04((cid:2)0.06,0.14),P¼.39 0.04 (cid:2)0.03 (cid:2)0.03
mean(SD), ((cid:2)0.11,0.05),
range7-49 P¼.49
IMI05, 5.9(3.6) 6.3(4.6) 5.5(4.8) 0.00((cid:2)0.04,0.05),P¼.96 0.00 (cid:2)0.01((cid:2)0.05,0.02),P¼.42 (cid:2)0.03 (cid:2)0.00((cid:2)0.04,0.04),P¼.98 0.00 (cid:2)0.01 (cid:2)0.02
mean(SD), ((cid:2)0.04,0.02),
range4-28 P¼.57
Psychological 60.0(10.2) 72.2(19.4) 75.1(23.0) 0.02((cid:2)0.12,0.17),P¼.74 0.01 (cid:2)0.08((cid:2)0.19,0.03),P¼.17 (cid:2)0.04 0.04((cid:2)0.10,0.18),P¼.60 0.02 (cid:2)0.01 (cid:2)0.01
well-being, ((cid:2)0.13,0.10),
mean(SD), P¼.81
range5-100
PASE,mean(SD), 61.2(42.6) 46.0(37.0) 38.6(38.3) (cid:2)0.07((cid:2)0.40,0.26),P¼.68 (cid:2)0.02 0.01((cid:2)0.25,0.26),P¼.97 0.00 (cid:2)0.10((cid:2)0.43,0.23),P¼.55 (cid:2)0.02 0.11 0.03
range0-400 ((cid:2)0.15,0.37),
P¼.41
GIP,mean(SD), 18.5(3.2) 18.2(3.8) 18.0(3.7) 0.00((cid:2)0.03,0.03),P¼.90 0.01 (cid:2)0.01((cid:2)0.04,0.01),P¼.30 (cid:2)0.04 0.00((cid:2)0.03,0.04),P¼.87 0.01 -0.00((cid:2)0.03,0.03), (cid:2)0.01
rangefrom5-24 P¼.89
Numberoffalls, 2.5(2.8) 1.2(0.5) 1.5(0.8) (cid:2)0.04((cid:2)0.10,0.03),P¼.26 (cid:2)0.20 (cid:2)0.01((cid:2)0.05,0.04),P¼.69 (cid:2)0.05 (cid:2)0.03((cid:2)0.11,0.05),P¼.41 (cid:2)0.17 (cid:2)0.00 (cid:2)0.02
mean(SD), ((cid:2)0.05,0.05),
during6-motrial P¼.89
EQ-5D-5LPwD, 0.7(0.3) 0.7(0.3) 0.8(0.2) 0.00((cid:2)0.00,0.00),P¼.73 0.01 (cid:2)0.00((cid:2)0.00,0.00),P¼.13 (cid:2)0.05 0.00((cid:2)0.00,0.00),P¼.63 0.02 (cid:2)0.00 (cid:2)0.04
mean(SD), ((cid:2)0.00,0.00),
range0-1 P¼.21
EQ-5D-5LIC_PwD, 0.4(0.3) 0.5(0.3) 0.5(0.3) 0.00((cid:2)0.00,0.00),P¼.21 0.05 0.00((cid:2)0.00,0.00),P¼.21 0.05 0.00((cid:2)0.00,0.00),P¼.17 0.06 0.00 0.05
mean(SD), ((cid:2)0.00,0.00),
range0-1 P¼.20
J.vanSantenetal./JAMDAxxx(2020)1e10
10.e3
Adj.,adjusted;ASCOT,AdultSocialCareOutcomesToolkit;BMI,bodymassindex;EQ-5D-5LPwD,qualityoflifeoftheparticipantwithdementiaasindicatedbyhimselforherself,usingtheEuroQol5dimensionsquestionnaire
with5-levelscalefromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScarerecipient);EQ-5D-5LIC_PwD,qualityoflifeoftheparticipantwithdementiaasindicatedbyhisorherinformal
caregiver,usingtheEuroQol5dimensionsquestionnairewith5-levelscalefromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScarerecipient);GIP,BehaviorObservationScaleforIntramural
Psychogeriatrics:subscale1Socialfunctioningoftheparticipantlivingwithdementiainthedaycarecenter;IMI01,IntrinsicMotivationInventory,subscale1interest/enjoymentinphysicalexercise;IMI02,IntrinsicMotivation
Inventory,subscale2perceivedcompetenceinphysicalexercise;IMI03,IntrinsicMotivationInventory,subscale3effortin/importanceofphysicalexercise;IMI04,IntrinsicMotivationInventory,subscale4perceivedchoiceof
physicalexercise;IMI05,IntrinsicMotivationInventory,subscale5value/usefulnessofphysicalexercise;MMSE,Mini-MentalStateExamination;PASE,PhysicalActivityScaleoftheElderly;Psychologicalwell-being,emotional
functioningfromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScarerecipient);PwD,participantwithdementia;SPPB,ShortPhysicalPerformanceBattery;TMT-A,TrailMakingTestpartA;
TMT-B,TrailMakingTestpartB.
Outcomesarewiththebaselinescore(T0)ontheMMSEofthePwDasaconfounder.Underlinedscoresaremorepositive.
*Dose-responseeffectsper10minutesmoreexergaming.
yOutcomescoresadjustedforconfoundingvariables:baselinescore(T0)ontheMMSE,BMI,sex,age,andlevelofeducationofthePwD.
zOutcomesarewithoutanyconfounders.
xOutcomescoresadjustedforconfoundingvariables:BMI,sex,age,andlevelofeducationofthePwD.
10.e4
J.vanSantenetal./JAMDAxxx(2020)1e10
SupplementaryTable5
TestScoresontheDifferentOutcomesperTimePoint,Dose-ResponseEffects,andEffectSizesforIC
OutcomeMeasures ExergamingGroup Dose-ResponseEffect*, EffectSize, Dose-Response EffectSize, Adj.Dose-Response Adj.Effect Adj.Dose-Response Adj.Effect
r(95%CI),PValue Cohend Effect*,r(95%CI), Cohend Effect*,r(95%CI), Size,Cohendy Effect*,r(95%CI), Size,
PValue PValuey PValuey Cohendy
T0 T1 T2 T1 T1 T2 T2 T1 T1 T2 T2
EQ-5D-5LIC, 0.9(0.1) 0.8(0.2) 0.9(0.2) (cid:2)0.00((cid:2)0.00,0.00),P¼.40 (cid:2)0.04 0.00((cid:2)0.00,0.00),P¼.88 0.01 (cid:2)0.00((cid:2)0.00,0.00),P¼.53 (cid:2)0.03 0.00 0.01
mean(SD), ((cid:2)0.00,0.00),
range0-1 P¼.76
CarerQoL, 81.0(16.0) 81.0(15.0) 83.0(12.0) 0.07((cid:2)0.06,0.20),P¼.27 0.05 0.09((cid:2)0.02,0.21),P¼.12 0.06 0.05((cid:2)0.08,0.17),P¼.48 0.03 0.08 0.05
mean(SD), ((cid:2)0.03,0.20),
range0-100 P¼.17
NPI-Qtotalseverity 10.6(6.3) 9.5(6.8) 7.3(6.3) (cid:2)0.00((cid:2)0.06,0.05),P¼.86 (cid:2)0.01 (cid:2)0.04((cid:2)0.09,0.02),P¼.18 (cid:2)0.06 (cid:2)0.01((cid:2)0.07,0.04),P¼.70 (cid:2)0.02 (cid:2)0.04 (cid:2)0.06
ofsymptoms, ((cid:2)0.09,0.02),
mean(SD), P¼.17
range0-36
NPI-Qtotaldistress, 12.3(9.0) 9.9(9.3) 8.2(8.0) (cid:2)0.02((cid:2)0.09,0.06),P¼.62 (cid:2)0.02 (cid:2)0.07((cid:2)0.14,0.01),P¼.08 (cid:2)0.08 (cid:2)0.02((cid:2)0.10,0.06),P¼.64 (cid:2)0.02 (cid:2)0.07 (cid:2)0.08
mean(SD), ((cid:2)0.15,0.00),
range0-60 P¼.06
NPI-Qtotalnumber 5.9(3.6) 7.0(4.0) 7.4(4.4) 0.02((cid:2)0.01,0.05),P¼.27 0.05 (cid:2)0.01((cid:2)0.03,0.02),P¼.54 (cid:2)0.02 0.03((cid:2)0.01,0.06),P¼.11 0.06 (cid:2)0.01 (cid:2)0.02
ofsymptoms, ((cid:2)0.03,0.02),
mean(SD), P¼.47
range0-12
SSCQ, 26.9(4.9) 27.7(5.0) 27.2(5.1) 0.02((cid:2)0.02,0.07),P¼.28 0.05 (cid:2)0.02((cid:2)0.06,0.02),P¼.43 (cid:2)0.03 0.03((cid:2)0.01,0.07),P¼.17 0.06 (cid:2)0.02 (cid:2)0.03
mean(SD), ((cid:2)0.05,0.02),
range7-35 P¼.44
PES,mean(SD), 4.8(1.8) 4.9(1.7) 5.1(1.5) 0.01((cid:2)0.01,0.02),P¼.41 0.03 0.00((cid:2)0.01,0.01),P¼.90 0.00 0.01((cid:2)0.01,0.02),P¼.35 0.04 0.00 0.01
range0-8 ((cid:2)0.01,0.01),
P¼.83
Adj.,adjusted;CarerQoL,qualityoflifeoftheinformalcaregiverusingtheCare-relatedQualityofLifeinstrumentfromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScaregiver);EQ-5D-5LIC,
qualityoflifeoftheinformalcaregiverusingtheEuroQol5dimensionsquestionnairewith5-levelscalefromTheOlderPersonsandInformalCaregiversSurveyMinimumDataSet(TOPICS-MDScarerecipient);IC,informal
caregiver;NPI-Qtotalseverityofsymptoms,totalseverityofsymptomsusingtheNeuropsychiatricInventoryeQuestionnaire;NPI-Qtotaldistress,totalamountofdistresscausedbythesymptomsasexperiencedbytheinformal
caregiverusingtheNeuropsychiatricInventoryeQuestionnaire;NPI-Qtotalnumberofsymptoms,totalnumberofsymptomsusingtheNeuropsychiatricInventoryeQuestionnaire;PES,positivecareexperiencesoftheinformal
caregiverusingScaleofPositiveExperiences[inDutch:PositieveErvaringenSchaal];SSCQ,subjectiveburdenfortheinformalcaregiverusingtheShortSenseofCompetenceQuestionnaire.
Outcomesarewiththebaselinescore(T0)ontheMMSEoftheparticipantwithdementia(PwD)asaconfounder.Underlinedscoresaremorepositive.
*Dose-responseeffectsper10minutesmoreexergaming.
yOutcomescoresadjustedforconfoundingvariables:thebaselinescore(T0)ontheMMSEofthePwDandsex,age,andlevelofeducationoftheIC.
J.vanSantenetal./JAMDAxxx(2020)1e10
10.e5
